688075 安旭生物
按盤價 
40.450 +0.050 (+0.124%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.647 | 2.688 | 75.847 | 43.212 | 1.330 |
| 總資產報酬率 ROA (%) | 2.344 | 2.222 | 59.516 | 33.712 | 98.405 |
| 投入資產回報率 ROIC (%) | 2.528 | 2.529 | 70.577 | 40.400 | 68.427 | 邊際利潤分析 |
| 銷售毛利率 (%) | 42.110 | 42.298 | 74.782 | 65.445 | 75.911 |
| 營業利潤率 (%) | 35.710 | 33.273 | 57.232 | 54.432 | 63.498 |
| 息稅前利潤/營業總收入 (%) | 37.352 | 14.479 | 48.426 | 55.856 | 66.250 |
| 淨利潤/營業總收入 (%) | 33.662 | 28.005 | 49.371 | 46.469 | 54.093 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 9.119 | 42.170 | 119.289 | 101.392 | 101.154 |
| 價值變動淨收益/利潤總額(%) | 78.450 | 59.315 | 1.392 | 1.381 | 0.166 |
| 營業外收支淨額/利潤總額(%) | 0.001 | -16.457 | -0.265 | -0.052 | -0.050 | 償債能力分析 |
| 流動比率 (X) | 8.963 | 8.788 | 4.569 | 4.533 | 3.581 |
| 速動比率 (X) | 8.661 | 8.428 | 4.424 | 4.162 | 3.135 |
| 資產負債率 (%) | 11.205 | 11.811 | 22.044 | 20.544 | 26.271 |
| 帶息債務/全部投入資本 (%) | 1.882 | 2.489 | 3.782 | 6.720 | -- |
| 股東權益/帶息債務 (%) | 5,104.924 | 3,815.547 | 2,465.186 | 1,379.401 | 3,063.419 |
| 股東權益/負債合計 (%) | 793.021 | 747.187 | 353.842 | 386.752 | 280.648 |
| 利息保障倍數 (X) | 22.744 | -1.027 | -5.596 | 38.454 | 23.799 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 150.442 | 155.982 | 22.029 | 86.606 | 0.000 |
| 存貨周轉天數 (天) | 208.426 | 244.442 | 51.010 | 121.161 | 0.000 |
| 備註： | 即時報價更新時間為 12/03/2025 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
